| dbo:abstract
|
- جيوفري لينغ (بالإنجليزية: Geoffrey Ling) هو عسكري أمريكي، ولد في القرن العشرين في بالتيمور في الولايات المتحدة. (ar)
- Geoffrey S. F. Ling, M.D., Ph.D., is the CEO of On Demand Pharmaceuticals. He is also a medical doctor who retired from the United States Army as a colonel. He served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2014 until 2016. He was considered to be the "US Army's premier subject matter expert on traumatic brain injury (TBI)", and was for years the only neuro-intensive care specialist in the US military. Prominent in his DARPA research portfolio are Preventing Violent Explosive Neuro Trauma (PREVENT), prevention of explosive blast traumatic brain injury, Revolutionizing Prostheses (RP), development of responsive, brain-controlled, artificial arms, Predicting Health and Disease (PHD), combination of biomarkers and advanced analytics to diagnosis of disease in the presymptomatic state and Battlefield Medicine, development of point-of-care drug manufacturing technology. He also served as a Program Manager and following, the Deputy Director of the Defense Sciences Office. Ling is recipient of the Department of Defense Medal for Distinguished Public Service, Legion of Merit, Alpha Omega Alpha, Sigma Xi and the Humanitarian Award from the Brain Mapping Foundation. In April of 2020, Ling co-wrote with Michael Stebbins the proposal for the creation of a new federal agency modeled on DARPA, but focused on health. That proposal was adopted by the President Biden's campaign and became the model used to establish the Advanced Research Projects Agency for Health (ARPA-H). (en)
|
